Ralf Michael Zwacka

researcher

Ralf Michael Zwacka is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0003-2821-0387

P108employerUniversity of EssexQ1075104
P735given nameRalfQ1245713
RalfQ1245713
P106occupationresearcherQ1650915

Reverse relations

author (P50)
Q39924087A non-apoptotic role for caspase-9 in muscle differentiation
Q57384595A novel method for the combined flow cytometric analysis of cell cycle and cytochrome c release
Q40582634AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression.
Q44115873Adenovirus-mediated manganese superoxide dismutase gene transfer to hamster cheek pouch carcinoma cells.
Q73444896Age-dependent hypertension in Mpv17-deficient mice, a transgenic model of glomerulosclerosis and inner ear disease
Q28183225Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells
Q38323803Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy
Q39505707Both human and mouse mesenchymal stem cells promote breast cancer metastasis.
Q37369909CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver
Q53867825Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis.
Q40218268Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells.
Q36215003DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer
Q37073589Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects
Q46872442Development of a FACS-based Smac/DIABLO release assay to monitor individual drug responses and to pave the way towards patient-tailored therapies.
Q51192946Effects of antioxidant enzyme overexpression on the invasive phenotype of hamster cheek pouch carcinoma cells.
Q38611997Expression of the recessive glomerulosclerosis gene Mpv17 regulates MMP-2 expression in fibroblasts, the kidney, and the inner ear of mice
Q34295898Functional rescue of the glomerulosclerosis phenotype in Mpv17 mice by transgenesis with the human Mpv17 homologue.
Q40849028Gene therapy for colon cancer.
Q39439318IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells
Q39541500Immunolocalization and adenoviral vector-mediated manganese superoxide dismutase gene transfer to experimental oral tumors
Q40188536In situ trapping of initiator caspases reveals intermediate surprises.
Q45856291Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis.
Q77355587Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation
Q48553142Loss of auditory function in transgenic Mpv17-deficient mice.
Q33925097Manganese superoxide dismutase induces p53-dependent senescence in colorectal cancer cells.
Q41051027Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity.
Q37310677Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model
Q40102576MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release.
Q45871895NF-kappaB kinetics predetermine TNF-alpha sensitivity of colorectal cancer cells
Q55469625NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition.
Q37679126Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells
Q43827486Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells.
Q34467287Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy.
Q35594351Reactive oxygen species in oncogenic transformation
Q64381763Recombinant adenovirus-mediated cardiac gene transfer of superoxide dismutase and catalase attenuates postischemic contractile dysfunction
Q45887796Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation.
Q41028918Redox gene therapy protects human IB-3 lung epithelial cells against ionizing radiation-induced apoptosis
Q43563087Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia/reperfusion
Q31825675Superoxide anions and endothelial cell proliferation in normoglycemia and hyperglycemia.
Q39645187TRAIL-induced apoptosis is preferentially mediated via TRAIL receptor 1 in pancreatic carcinoma cells and profoundly enhanced by XIAP inhibitors
Q39649739Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells
Q39862039The TRAIL-receptor-1: TRAIL-receptor-3 and -4 ratio is a predictor for TRAIL sensitivity of cancer cells.
Q37342739The enigmatic roles of caspases in tumor development
Q24336548The glomerulosclerosis gene Mpv17 encodes a peroxisomal protein producing reactive oxygen species
Q34347731The human homolog of the glomerulosclerosis gene Mpv17: structure and genomic organization
Q34738743The yeast TEL1 gene partially substitutes for human ATM in suppressing hyperrecombination, radiation-induced apoptosis and telomere shortening in A-T cells
Q33763851Therapeutic approaches for ischemia/reperfusion injury in the liver.
Q79834427Vitamin D3-24-hydroxylase (CYP24) as a potential target for intervention with diabetic and nondiabetic nephropathy
Q79889958[Gene therapy strategies for colorectal cancer]

Search more.